Which guesstimate is the best guesstimate? Predicting chemotherapeutic outcomes

Nature Medicine

Volumn 3, Issue 9, 1997, Pages 962-963

  Lamb, John R ^a   Friend, Stephen H ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; CANCER GROWTH; CANCER RESEARCH; CANCER RESISTANCE; CELL SURVIVAL; COLON CARCINOMA; CYTOTOXICITY; DNA DAMAGE; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; DRUG SCREENING ASSAYS, ANTITUMOR; GENES, P53; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

ANIMALIA;

EID: 0030759950     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0997-962     Document Type: Short Survey

References (14)

1. Hartwell, L., Weinert, T., Kadyk, L. & Garvik, B. Cell cycle checkpoints, genomic integrity, and cancer. Cold Spring Harbor Symp. Quant. Biol. 59, 259-263 (1994).
2. Friedberg, E.C., Walker, G.C. & Siede, W. In DNA repair and mutagenesis. pages 633-670 (ASM Press, Washington, D.C., 1995).
3. Waldman, T. et al. Cell cycle arrest versus cell death in cancer therapy. Nature Med. 3, 1034-1036 (1997).
4. Waldman, T., Lengauer, C., Kinzler, K.W. & Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713-716 (1996).
5. Borresen, A. et al. p53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chromosomes Cancer 14, 71-75 (1995).
6. WAF1/CIP1-/- human cancer cells. Cancer Res. 56, 2250-2255 (1996).
7. Rofstad, E.K. Radiation biology of human tumour xenografts. Int. J. Radiat. Biol. 56, 573-581 (1989).
8. DeVita, J.V.T. Principles of cancer management: chemotherapy. In Cancer: principles and practice of oncology (eds DeVita, J.V.T., Hellman, S. & Rosenberg, S.A.) pages 333-348 (Lippincott-Raven, Philadelphia, New York, 1997).
9. Rofstad, E.K. Comparative sensitivity of cells from human tumors and derivative tumor xenografts to radiation and heat treatments. J. Natl. Cancer Inst. 84, 1517-1524 (1992).
10. Puck, T. T., Marcus, P. I. & Cieciura, S. J. Clonal growth of mammalian cells in vitro. J. Exp. Med. 103, 273-289 (1956).
11. Paulovich, A.G., Toczyski, D.P. & Hartwell, L.H. When checkpoints fail. Cell 88, 315-321 (1997).
12. Bae, I. et al. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines. Cancer Res. 56, 840-847 (1996).
13. Clarke, A.R. et al. Thymocyte apoptosis induced by p53 dependent and independent pathways. Nature 362, 849-851 (1993).
14. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. & Jacks, T. p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362, 847-849 (1993).